All of these results demonstrated that HK2 altered cell cycle progression by upregulating c-myc and CyclinD1 expression through activating Wnt/β-catenin pathway in ovarian cancer cells, further promoting cell proliferation. This evidence concerns the gene MYC and ovarian cancer.